Literature DB >> 9484777

Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas.

J M Geurts1, E F Schoenmakers, E Röijer, A K Aström, G Stenman, W J van de Ven.   

Abstract

Approximately 12% of all pleomorphic adenomas of the salivary glands are characterized by chromosome aberrations involving the chromosome segment 12q13-15. Several chromosomes have been found as translocation partners of chromosome 12, and some of these recurrently. Recently, the HMGIC gene was identified as the target gene affected by the 12q13-15 aberrations. Here, we report the identification and characterization of a new translocation partner gene of HMGIC in pleomorphic adenomas. 3'-RACE analysis of a primary adenoma with an apparently normal karyotype revealed an HMGIC fusion transcript containing ectopic sequences derived from the human NFIB gene, previously mapped to chromosome band 9p24.1. The HMGIC NFIB fusion transcript was also confirmed by RT-PCR. Since the chromosome segment 9p12-24 is repeatedly involved as translocation partner of chromosome 12q13-15 in pleomorphic adenomas, we tested whether NFIB might be a recurrent partner of HMGIC. RT-PCR analysis of a second adenoma with an ins(9;12)(p23;q12q15) as the sole anomaly, revealed that also in this tumor an HMGIC/NFIB hybrid transcript was present. The reciprocal NFIB/HMGIC fusion transcript, however, could not be detected in any of these tumors. Nucleotide sequence analysis of the fusion transcripts indicated that the genetic aberration in both tumors resulted in the replacement of a carboxy-terminal segment of HMGIC by the last five amino acids of NFIB. In conclusion, our results reveal the recurrent involvement of the NFIB gene as translocation partner gene of HMGIC in pleomorphic adenomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484777     DOI: 10.1038/sj.onc.1201609

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

Review 1.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

2.  Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours.

Authors:  B K Nayak; B R Das
Journal:  Mol Biol Rep       Date:  1999-12       Impact factor: 2.316

3.  Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.

Authors:  Nora Katabi; Ronald Ghossein; Alan Ho; Snjezana Dogan; Lei Zhang; Yun-Shao Sung; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2014-09-07       Impact factor: 3.466

Review 4.  [Immunohistochemical characterization of salivary gland tumors with tissue micro-arrays].

Authors:  K Röser; K T Jäkel; H Herbst; T Löning
Journal:  Pathologe       Date:  2005-09       Impact factor: 1.011

5.  Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Authors:  Jennelle C Hodge; Tae-Min Kim; Jonathan M Dreyfuss; Priya Somasundaram; Nicole C Christacos; Marissa Rousselle; Bradley J Quade; Peter J Park; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

6.  Fusion of the HMGA2 and NFIB genes in lipoma.

Authors:  M Nilsson; I Panagopoulos; F Mertens; N Mandahl
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

7.  PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study.

Authors:  Atsuji Matsuyama; Masanori Hisaoka; Hiroshi Hashimoto
Journal:  Virchows Arch       Date:  2011-09-17       Impact factor: 4.064

8.  [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].

Authors:  A Fehr; G Stenman; J Bullerdiek; T Löning
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

9.  Nuclear factor one transcription factors in CNS development.

Authors:  Sharon Mason; Michael Piper; Richard M Gronostajski; Linda J Richards
Journal:  Mol Neurobiol       Date:  2008-12-05       Impact factor: 5.590

Review 10.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.